Short term efficacy of paclitaxel combined with carboplatin in concurrent radiotherapy for advanced cervical cancer
Objective To study and analyze the short-term efficacy of paclitaxel combined with carboplatin chemotherapy in the treatment of advanced cervical cancer. Methods 60 cases of advanced cervical cancer patients in our hospital as the research object, the control group was treated by radiotherapy, patients in the experimental group were treated with paclitaxel and carboplatin chemotherapy combined radiotherapy treatment, paclitaxel 135 mg/m2 intravenous drip, intravenous injection of carboplatin. Comparative analysis of the experimental group and the control group of short-term efficacy, adverse reactions and other clinical indicators. Results The effective rate of the experimental group was 80.0%, which was significantly higher than that of the control group, and the effective rate was 50.0%, with statistical difference (P<0.05). The adverse reaction rate in the control group was 53.3%, which was significantly higher than that in the experimental group, and the adverse reaction rate was 36.7%, which was statistically significant (P<0.05). Conclusion Paclitaxel combined with carboplatin chemotherapy in the treatment of advanced cervical cancer with concurrent radiotherapy is effective, safe and low incidence of adverse reactions.
NETL
NSTL
万方数据
